LifePoint Health (LPNT) Releases FY18 Earnings Guidance

LifePoint Health (NASDAQ:LPNT) updated its FY18 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $4.00-4.53 for the period, compared to the Thomson Reuters consensus estimate of $4.09. The company issued revenue guidance of $6.35-6.43 billion, compared to the consensus revenue estimate of $6.49 billion.

A number of brokerages have recently issued reports on LPNT. Cantor Fitzgerald reiterated a hold rating and set a $50.00 price target on shares of LifePoint Health in a research report on Friday. Robert W. Baird set a $55.00 price target on LifePoint Health and gave the company a buy rating in a research report on Monday, October 30th. BidaskClub upgraded LifePoint Health from a sell rating to a hold rating in a research report on Thursday, January 11th. ValuEngine downgraded LifePoint Health from a buy rating to a hold rating in a research report on Friday, February 2nd. Finally, Zacks Investment Research upgraded LifePoint Health from a strong sell rating to a hold rating in a research report on Monday, January 22nd. One research analyst has rated the stock with a sell rating, fifteen have issued a hold rating and five have issued a buy rating to the company. The stock has an average rating of Hold and an average target price of $58.13.

LifePoint Health (LPNT) traded up $0.60 during trading hours on Friday, reaching $49.70. The company had a trading volume of 601,000 shares, compared to its average volume of 539,309. The company has a market cap of $1,935.31, a P/E ratio of 11.75, a price-to-earnings-growth ratio of 1.12 and a beta of 0.52. LifePoint Health has a one year low of $41.45 and a one year high of $67.95. The company has a quick ratio of 1.65, a current ratio of 1.85 and a debt-to-equity ratio of 1.24.

LifePoint Health (NASDAQ:LPNT) last released its earnings results on Friday, February 23rd. The company reported $0.77 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.83 by ($0.06). The firm had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.58 billion. LifePoint Health had a return on equity of 7.01% and a net margin of 2.45%. The business’s quarterly revenue was down 7.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.07 EPS. research analysts anticipate that LifePoint Health will post 3.64 EPS for the current fiscal year.

LifePoint Health announced that its board has authorized a share buyback program on Friday, October 27th that permits the company to repurchase $200.00 million in shares. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.

In related news, insider David M. Dill sold 45,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 16th. The stock was sold at an average price of $48.52, for a total value of $2,183,400.00. Following the completion of the sale, the insider now owns 252,673 shares in the company, valued at approximately $12,259,693.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Marguerite Kondracke sold 3,907 shares of the business’s stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $44.73, for a total value of $174,760.11. The disclosure for this sale can be found here. Insiders own 8.76% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This article was published by Week Herald and is the property of of Week Herald. If you are reading this article on another website, it was illegally stolen and republished in violation of international copyright and trademark laws. The legal version of this article can be read at

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Earnings History and Estimates for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with's FREE daily email newsletter.

Leave a Reply